BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26329623)

  • 1. [Immunohistochemical Analysis of Krebs von den Lungen-6 (KL-6) Expression in Lung Tissue in Primary Lung Cancer Patients with High Serum KL-6 Levels].
    Yatsuyanagi E; Sato K; Sato K
    Kyobu Geka; 2015 Sep; 68(10):815-9. PubMed ID: 26329623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
    Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
    Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of colon cancer by increased serum level of Krebs von den Lungen-6 in a patient with dermatomyositis-associated interstitial pneumonia.
    Fukuhara N; Tanino Y; Sato S; Fukuhara A; Uematsu M; Nikaido T; Misa K; Sato Y; Saito J; Wang X; Munakata M
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):265-70. PubMed ID: 26422573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.
    Tomita M; Ayabe T; Chosa E; Nose N; Nakamura K
    Gen Thorac Cardiovasc Surg; 2016 Nov; 64(11):657-661. PubMed ID: 27515028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
    Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
    Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Krebs von den Lungen-6 as a predictor of relapse in interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies-positive dermatomyositis.
    Isoda K; Kotani T; Takeuchi T; Konma J; Ishida T; Hata K; Otani K; Fujiwara H; Shoda T; Makino S; Arawaka S
    Clin Respir J; 2018 Jul; 12(7):2235-2241. PubMed ID: 29633527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the clinical performance of the HISCL-5000 analyzer in the detection of Krebs von den Lungen-6 antigen and its diagnostic value in interstitial lung disease.
    Wang J; Huang Z; Xue M; Huang H; Zheng X; Zhong N; Sun B
    J Clin Lab Anal; 2020 Feb; 34(2):e23070. PubMed ID: 31691368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical and Clinical Performance of the Nanopia Krebs von den Lungen 6 Assay in Korean Patients With Interstitial Lung Diseases.
    Cho EJ; Park KJ; Ko DH; Koo HJ; Lee SM; Song JW; Lee W; Lee HK; Do KH; Chun S; Min WK
    Ann Lab Med; 2019 May; 39(3):245-251. PubMed ID: 30623616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Impact for Postoperative Recurrence of Preoperative Serum Krebs von den Lungen-6 Concentration in Pathologic Stage IA Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 May; 101(5):1903-8. PubMed ID: 26912302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease.
    Kuwana M; Shirai Y; Takeuchi T
    J Rheumatol; 2016 Oct; 43(10):1825-1831. PubMed ID: 27481907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anti-interleukin-17 biologics on Krebs von den Lungen-6 level in patients with psoriasis.
    Hara H; Miyagawa H; Araya J; Minagawa S; Numata T; Umezawa Y; Asahina A; Nakagawa H; Kuwano K
    J Dermatol; 2021 Jun; 48(6):886-893. PubMed ID: 33860559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome.
    Kase S; Kitaichi N; Namba K; Miyazaki A; Yoshida K; Ishikura K; Ikeda M; Nakashima T; Ohno S
    Am J Kidney Dis; 2006 Dec; 48(6):935-41. PubMed ID: 17162148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic value of serum KL-6 in connective tissue disease associated interstitial lung disease].
    Wu X; Wu LJ; Luo CN; Shi YM; Zou JM; Meng XY
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3172-3175. PubMed ID: 31694110
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical Usefulness of Serum Krebs von den Lungen-6 for Detecting Chronic Aspiration in Children with Severe Motor and Intellectual Disabilities.
    Wakamoto H; Sano N; Yano Y; Sakai S; Kikuchi T; Fukuda M; Morimoto T; Ishii E
    J Pediatr; 2015 Nov; 167(5):1136-42. PubMed ID: 26382626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study.
    Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Kohno N; Hattori N
    Medicine (Baltimore); 2018 Dec; 97(49):e13542. PubMed ID: 30544464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum KL-6 concentrations are associated with molecular sizes and efflux behavior of KL-6/MUC1 in healthy subjects.
    Shigemura M; Konno S; Nasuhara Y; Shijubo N; Shimizu C; Nishimura M
    Clin Chim Acta; 2013 Sep; 424():148-52. PubMed ID: 23778023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secukinumab decreases serum Krebs von den Lungen 6 (KL-6) level in patients with psoriasis with elevated serum KL-6 level.
    Chijiwa C; Takeoka S; Kamata M; Uchida H; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    Br J Dermatol; 2018 Dec; 179(6):1396-1397. PubMed ID: 29985537
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevation of serum KL-6 in patients with psoriasis treated with anti-tumour necrosis factor-α therapy.
    Higashi Y; Tada K; Shimokawa M; Kawai K; Kanekura T
    Clin Exp Dermatol; 2016 Jan; 41(1):88-90. PubMed ID: 25557847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.
    Ishikawa N; Hattori N; Yokoyama A; Kohno N
    Respir Investig; 2012 Mar; 50(1):3-13. PubMed ID: 22554854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease.
    Takanashi S; Nishina N; Nakazawa M; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2019 Jun; 58(6):1034-1039. PubMed ID: 30624752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.